Journals
Publish with us
Publishing partnerships
About us
Blog
BioMed Research International
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
BioMed Research International
/
2015
/
Article
/
Tab 2
/
Review Article
Environmental Epigenetics: Crossroad between Public Health, Lifestyle, and Cancer Prevention
Table 2
Epigenetic modifier drugs in noncancer clinical trials (partial list).
Drug
Disease
NCT number
Phase
5-Azacitidine
Beta thalassemia
NCT00005934
Phase 2
5-Azacytidine + Na phenylbutyrate
Thalassemia major
NCT00007072
Phase 2
Resveratrol
Cardiovascular diseases
NCT01449110
Phase 2
Resveratrol
Trauma
NCT01321151
Phase 1
Resveratrol
Metabolic syndrome, obesity
NCT01150955
Phase 1
Curcumin
Irritable bowel syndrome
NCT00779493
Phase 4
Curcumin
Alzheimer disease
NCT00164749
Phase 2
Curcumin
Psoriasis
NCT00235625
Phase 2